Allograft osteochondral transplantation in the knee in the active duty population

The purpose of this study is to analyze the role of allograft osteochondral transplantation in the knee in the active duty population, focusing on the patient's ability to remain on active duty following the procedure. A retrospective review was performed on all active duty patients undergoing allograft osteochondral transplantation surgery of the knee at our institution from 2003 to 2011. Medical records were reviewed for patient characteristics and treatment details. Eighteen patients underwent osteochondral transplantation surgery from 2003 to 2011. One of the patients is still in the acute recovery phase of their procedure (<1 year since surgery), and one patient was already in the medical evaluation board (MEB) process at the time of surgery. Of the remaining sixteen patients, nine have either entered or completed the MEB since surgery. Six of the seven patients who have stayed on active duty remain on activity-restricting profiles. The average time from surgery to MEB for these patients was 23.2 months. In the setting of the unique demands of active duty soldiers, osteochondral allograft transplantation does not appear to be conducive to retention on active duty.